- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
San Ramon Today
By the People, for the People
Quantitative Investment Management Boosts Stake in Cooper Companies
The institutional investor increased its holdings in the medical device company by over 110% in the third quarter.
Mar. 13, 2026 at 10:40am
Got story updates? Submit your updates here. ›
Quantitative Investment Management LLC, an institutional investor, increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 111.8% in the third quarter, according to a recent 13F filing with the Securities & Exchange Commission. The firm now owns 36,024 shares of the medical device company's stock, valued at $2,469,000.
Why it matters
Cooper Companies is a major player in the vision care and women's health products markets, and changes in institutional ownership can signal broader market sentiment about the company's performance and outlook.
The details
According to the 13F filing, Quantitative Investment Management LLC purchased an additional 19,014 shares of Cooper Companies during the third quarter, increasing its total holdings to 36,024 shares. The institutional investor's stake in the company is now valued at $2,469,000.
- Quantitative Investment Management LLC increased its stake in Cooper Companies during the third quarter of 2026.
The players
Quantitative Investment Management LLC
An institutional investor that manages a portfolio of investments.
The Cooper Companies, Inc.
A global medical device company that develops, manufactures, and markets a broad range of soft contact lenses and related accessories, as well as women's health products.
The takeaway
The increase in Quantitative Investment Management's stake in Cooper Companies suggests the institutional investor sees potential in the medical device company's performance and growth prospects, which could signal broader market confidence in the firm's future.


